Universal absence of merlin, but not other ERM family members, in schwannomas - PubMed (original) (raw)
. 1997 Dec;151(6):1649-54.
Affiliations
- PMID: 9403715
- PMCID: PMC1858373
Universal absence of merlin, but not other ERM family members, in schwannomas
A O Stemmer-Rachamimov et al. Am J Pathol. 1997 Dec.
Abstract
NF2 (neurofibromatosis 2, encoding the merlin protein) gene mutations and chromosome 22q loss have been demonstrated in the majority of sporadic and NF2-associated schwannomas, but many schwannomas fail to demonstrate genetic evidence of biallelic NF2 gene inactivation. In addition, the role of the merlin-related ERM family members (ezrin, radixin, and moesin) remains unclear in these tumors. We therefore studied expression of NF2-encoded merlin as well as ezrin, radixin, and moesin in 22 vestibular and peripheral schwannomas that had been evaluated for NF2 mutations and chromosome 22q loss. Western blotting and immunohistochemistry with antibodies directed against the amino and carboxy termini of merlin demonstrated loss of merlin expression in all studied schwannomas, including 12 tumors lacking genetic evidence of biallelic NF2 gene inactivation. Western blotting with antibodies directed against ezrin, radixin, and moesin, however, showed expression of these proteins in all schwannomas. In addition, immunohistochemistry with an antibody to moesin revealed widespread expression in tumor and endothelial cells. These data indicate that the specific loss of merlin is universal to schwannomas and is not linked to loss of ezrin, radixin, or moesin expression.
Similar articles
- Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
Stemmer-Rachamimov AO, Gonzalez-Agosti C, Xu L, Burwick JA, Beauchamp R, Pinney D, Louis DN, Ramesh V. Stemmer-Rachamimov AO, et al. J Neuropathol Exp Neurol. 1997 Jun;56(6):735-42. J Neuropathol Exp Neurol. 1997. PMID: 9184664 - Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ, Lowrie DJ, Sun H, Dorsey E, Pelton PD, Bashour AM, Groden J, Ratner N, Ip W. Meng JJ, et al. J Neurosci Res. 2000 Nov 15;62(4):491-502. doi: 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D. J Neurosci Res. 2000. PMID: 11070492 - Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M, Sainio M, Zhao F, Heiska L, Vaheri A, Carpén O. Grönholm M, et al. J Cell Sci. 1999 Mar;112 ( Pt 6):895-904. doi: 10.1242/jcs.112.6.895. J Cell Sci. 1999. PMID: 10036239 - [Neurofibromatosis type 2 (NF2)].
Araki N, Takeshima H, Saya H. Araki N, et al. Gan To Kagaku Ryoho. 1997 Sep;24(11):1427-31. Gan To Kagaku Ryoho. 1997. PMID: 9309136 Review. Japanese. - NF2: the wizardry of merlin.
Xiao GH, Chernoff J, Testa JR. Xiao GH, et al. Genes Chromosomes Cancer. 2003 Dec;38(4):389-99. doi: 10.1002/gcc.10282. Genes Chromosomes Cancer. 2003. PMID: 14566860 Review.
Cited by
- Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear.
Sandison A. Sandison A. Head Neck Pathol. 2022 Mar;16(1):76-86. doi: 10.1007/s12105-022-01450-9. Epub 2022 Apr 9. Head Neck Pathol. 2022. PMID: 35397067 Free PMC article. - Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.
Goutebroze L, Brault E, Muchardt C, Camonis J, Thomas G. Goutebroze L, et al. Mol Cell Biol. 2000 Mar;20(5):1699-712. doi: 10.1128/MCB.20.5.1699-1712.2000. Mol Cell Biol. 2000. PMID: 10669747 Free PMC article. - Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma.
Singh A, Mishra AK, Ylaya K, Hewitt SM, Sharma KC, Saxena S. Singh A, et al. Pathol Oncol Res. 2012 Apr;18(2):383-9. doi: 10.1007/s12253-011-9456-x. Epub 2011 Sep 10. Pathol Oncol Res. 2012. PMID: 21909685 Free PMC article. - The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.
Clark JJ, Provenzano M, Diggelmann HR, Xu N, Hansen SS, Hansen MR. Clark JJ, et al. Otol Neurotol. 2008 Sep;29(6):846-53. doi: 10.1097/MAO.0b013e31817f7398. Otol Neurotol. 2008. PMID: 18636037 Free PMC article. - NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
Sato T, Sekido Y. Sato T, et al. Int J Mol Sci. 2018 Mar 26;19(4):988. doi: 10.3390/ijms19040988. Int J Mol Sci. 2018. PMID: 29587439 Free PMC article. Review.
References
- Genes Chromosomes Cancer. 1994 Sep;11(1):7-14 - PubMed
- Cancer Res. 1995 Mar 15;55(6):1227-31 - PubMed
- J Cell Sci. 1994 Sep;107 ( Pt 9):2523-34 - PubMed
- Hum Mol Genet. 1995 Jan;4(1):137-9 - PubMed
- Exp Cell Res. 1995 Jul;219(1):180-96 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous